Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
Respiratory Research Sep 29, 2017
Fahndrich S, et al. - This study was performed in alpha-1-antitrypsin deficiency (AATD) patients within the German COPD cohort study COSYCONET (ÂCOPD and SYstemic consequences-COmorbidities NETworkÂ) cohort in order to analyze the clinical phenotype of AATD patients, emphasizing on the distribution of comorbidities. Findings demonstrated an association of AATD with a lower prevalence of cardiovascular disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries